Dr. Raymond Thertulien
Claim this profileAdventHealth Infusion Center Asheville
Expert in Cancer
Studies Multiple Myeloma
25 reported clinical trials
67 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Multiple Myeloma
Affiliated Hospitals
Clinical Trials Raymond Thertulien is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Raymond Thertulien
Clinical Trial Related4 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Raymond Thertulien has experience with
- Lenalidomide
- Cyclophosphamide
- Carboplatin
- Nivolumab
- Idecabtagene Vicleucel
- Fludarabine
Breakdown of trials Raymond Thertulien has run
Cancer
Multiple Myeloma
Plasma Cell Neoplasms
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Raymond Thertulien specialize in?
Raymond Thertulien focuses on Cancer and Multiple Myeloma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Raymond Thertulien currently recruiting for clinical trials?
Yes, Raymond Thertulien is currently recruiting for 9 clinical trials in Asheville North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Raymond Thertulien has studied deeply?
Yes, Raymond Thertulien has studied treatments such as Lenalidomide, Cyclophosphamide, Carboplatin.
What is the best way to schedule an appointment with Raymond Thertulien?
Apply for one of the trials that Raymond Thertulien is conducting.
What is the office address of Raymond Thertulien?
The office of Raymond Thertulien is located at: AdventHealth Infusion Center Asheville, Asheville, North Carolina 28803 United States. This is the address for their practice at the AdventHealth Infusion Center Asheville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.